Interleukin Genetics, Inc. (ILIU) Starts Presentation at 2015 Marcum MicroCap Conference

Interleukin Genetics develops and markets proprietary genetic tests for chronic diseases and health-related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intellectual property and genetic panel development expertise in metabolism and inflammation to facilitate the emerging personalized healthcare market. The company markets its tests through partnerships with health and wellness companies, healthcare professionals and other distribution channels. For more information, visit the company’s website at www.ilgenetics.com